AGI-14100
AGI-14100 is a novel and orally available mIDH1 inhibitor.AGI-14100 is used for the treatment of primary human myeloid leukemia.
Product Specifications
CAS Number
1448346-43-7
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
599.96
Molecular Formula
C29H22ClF4N5O3
Notes
Research use only, not for human use.
Receptor
Dehydrogenase
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items